Link to this page
Medical Subject Headings
Last uploaded:
March 22, 2026
| Id | http://purl.bioontology.org/ontology/MESH/C000627630
http://purl.bioontology.org/ontology/MESH/C000627630
|
|---|---|
| Preferred Name | ivosidenib |
| Synonyms |
N-((1S)-1-(2-chlorophenyl)-2-((3,3-difluorocyclobutyl)amino)-2-oxoethyl)-1-(4-cyano-2-pyridinyl)-N-(5-fluoro-3-pyridinyl)-5-oxo-L-prolinamide
Tibsovo
AG-120
AG120
|
| Type | http://www.w3.org/2002/07/owl#Class |
All Properties
| altLabel | N-((1S)-1-(2-chlorophenyl)-2-((3,3-difluorocyclobutyl)amino)-2-oxoethyl)-1-(4-cyano-2-pyridinyl)-N-(5-fluoro-3-pyridinyl)-5-oxo-L-prolinamide
Tibsovo
AG-120
AG120
|
|---|---|
| prefLabel | ivosidenib
|
| Scope Statement | an inhibitor of isocitrate dehydrogenase 1 (IDH1) for treatment of acute myeloid leukemia (AML)
|
| type | |
| isa | |
| PA |
D004791
D000970
|
| tui |
T109
T121
|
| Has mapping qualifier | |
| HM |
D011725
D005998/Q000031
|
| SC | 1
|
| TERMUI |
T000944919
T001122824
T000944918
T001000231
T000944917
|
| TH |
NLM (2020)
FDA SRS (2017)
NLM (2022)
USAN (19XX)
INN (19XX)
NLM (2017)
See more
See less
|
| SRC | N Engl J Med. 2018 Jun 21;378(25):2386-2398.
|
| MMR | 20220728
|
| notation | C000627630
|
| Semantic type UMLS property | |
| cui |
C4704617
C3827169
C4682397
|
| MeSH Frequency | 83
|
| LT | TRD
|
| DSC | 20180716
|
| Inverse of RB | Q2PCN8MAM6
|
| Mapped to | |
| MDA | 20180716
|
| Delete | Subject | Author | Type | Created |
|---|---|---|---|---|
| No notes to display |